ライフサイエンスコーパス: crevicular

1 The use of crevicular AST activity to monitor periodontal disease p

2 udy examined conditions under which gingival crevicular blood (GCB) could be used to obtain a useful

3 l diabetes screening approach using gingival crevicular blood (GCB) could be used to test for hemoglo

4 GCF), a marker of neutrophil influx into the crevicular environment, has previously been shown to be

5 talloproteinase-9 (MMP-9) levels in gingival crevicular fluid (GCF) across various periodontal health

6 ociation with plaque index (PI) and gingival crevicular fluid (GCF) after OHR for 1 week.

7 le is known about MMP reductions in gingival crevicular fluid (GCF) after therapy.

8 and local inflammatory mediators in gingival crevicular fluid (GCF) among patients with untreated chr

9 testing, histological examination, gingival crevicular fluid (GCF) analysis for the levels of C-telo

10 at in chronic periodontitis (CP) by gingival crevicular fluid (GCF) analysis of myeloperoxidase (MPO)

11 eri-implant crevicular fluid (PICF)/gingival crevicular fluid (GCF) and a selection of subgingival/su

12 At each visit, gingival crevicular fluid (GCF) and blood were collected for dete

13 pecific FN fragments are present in gingival crevicular fluid (GCF) and can be used as markers for pe

14 ere to delineate cyto/chemokines in gingival crevicular fluid (GCF) and evaluate systemic levels of e

15 evels of stress-related hormones in gingival crevicular fluid (GCF) and extent/severity of periodonta

16 PAF levels were investigated in gingival crevicular fluid (GCF) and gingival tissue (GT) samples

17 LTB4 levels were investigated in gingival crevicular fluid (GCF) and gingival tissue (GT) samples

18 The gingival crevicular fluid (GCF) and monocytic secretion of prosta

19 surgery on growth factor levels in gingival crevicular fluid (GCF) and periodontal healing.

20 s, and levels of cyto/chemokines in gingival crevicular fluid (GCF) and peripheral blood response.

21 the present study is to investigate gingival crevicular fluid (GCF) and plasma acute-phase cytokines,

22 s study is to investigate levels of gingival crevicular fluid (GCF) and plasma TGM-2 and oxidative st

23 d subgingival bacteria collected in gingival crevicular fluid (GCF) and RA parameters.

24 This study aimed to investigate the gingival crevicular fluid (GCF) and salivary HIF-1alpha, VEGF, an

25 nitial periodontal treatment on the gingival crevicular fluid (GCF) and salivary levels of 8-hydroxy-

26 ng pregnancy on periodontal health, gingival crevicular fluid (GCF) and serum cytokines, and pregnanc

27 This study aimed to investigate gingival crevicular fluid (GCF) and serum levels of LRG, interleu

28 This study aimed to investigate gingival crevicular fluid (GCF) and serum levels of LRG, interleu

29 This study is performed to evaluate gingival crevicular fluid (GCF) and serum levels of soluble recep

30 evaluate YKL-40 and IL-6 levels in gingival crevicular fluid (GCF) and serum of patients with period

31 To evaluate the cytokine profile in gingival crevicular fluid (GCF) and serum of pediatric inflammato

32 nti-inflammatory cytokine levels in gingival crevicular fluid (GCF) and serum of rheumatoid arthritis

33 gical periodontal therapy (NSPT) on gingival crevicular fluid (GCF) and serum progranulin (PGRN) leve

34 mor necrosis factor (TNF)-alpha, in gingival crevicular fluid (GCF) and serum samples between women w

35 idative stress index (OSI) in their gingival crevicular fluid (GCF) and serum were recorded.

36 At baseline, gingival crevicular fluid (GCF) and subgingival plaque were colle

37 Gingival crevicular fluid (GCF) and subgingival plaque were colle

38 growth factor-beta 1 (TGF-beta1) in gingival crevicular fluid (GCF) and the periodontal status of sub

39 ith apoptosis in serum, saliva, and gingival crevicular fluid (GCF) and their association with period

40 is-specific molecular signatures in gingival crevicular fluid (GCF) and to confirm clinical diagnoses

41 antibody responses in non-invasive gingival crevicular fluid (GCF) and unstimulated whole saliva to

42 s and RANKL/OPG ratios in serum and gingival crevicular fluid (GCF) are investigated in patients with

43 Volumetric alterations in gingival crevicular fluid (GCF) are widely accepted to be associa

44 implant crevicular fluid (PICF) and gingival crevicular fluid (GCF) as surrogate measures of immune f

45 tudy is to determine whether either gingival crevicular fluid (GCF) bacterial gingivain/gingipain or

46 his study were to measure levels of gingival crevicular fluid (GCF) biomarkers and subgingival bacter

47 Gingival crevicular fluid (GCF) biomarkers associated with bone r

48 n serum, synovial fluid, saliva and gingival crevicular fluid (GCF) by multiplex immunoassay.

49 study are to: 1) determine whether gingival crevicular fluid (GCF) chemerin is a novel predictive ma

50 n unbiased metabolomic profiling of gingival crevicular fluid (GCF) collected from healthy, gingiviti

51 Aa), Tannerella forsythia (Tf), and gingival crevicular fluid (GCF) concentration of interleukin (IL)

52 present with increased salivary and gingival crevicular fluid (GCF) concentrations of cytokines.

53 this study was to compare serum and gingival crevicular fluid (GCF) concentrations of sICAM-1 in smok

54 ue, suggesting that their levels in gingival crevicular fluid (GCF) could be increased at gingivitis

55 gival plaque microbial profiles and gingival crevicular fluid (GCF) cytokine levels were determined b

56 It may be hypothesized that the gingival crevicular fluid (GCF) cytokine profile in patients with

57 l periodontal therapy (NSPT) on the gingival crevicular fluid (GCF) cytokine profile in sites with st

58 rived growth factor-BB (PDGF-BB) in gingival crevicular fluid (GCF) during early healing period after

59 metalloproteinase (MMP)-8 and -9 in gingival crevicular fluid (GCF) during early pregnancy with the p

60 he study are to determine serum and gingival crevicular fluid (GCF) endocan levels in the pathogenesi

61 s, systemic priming of neutrophils, gingival crevicular fluid (GCF) expression of inflammatory marker

62 Gingival crevicular fluid (GCF) flow was significantly lower in t

63 F) samples from the new implant and gingival crevicular fluid (GCF) from adjacent teeth were sampled

64 ence of Th1-associated cytokines in gingival crevicular fluid (GCF) from LagP patients and the high l

65 -derived growth factor (PDGF-BB) in gingival crevicular fluid (GCF) from localized intrabony defects

66 f human herpesviruses in saliva and gingival crevicular fluid (GCF) from patients with CKD.

67 n-surgical periodontal treatment on gingival crevicular fluid (GCF) HIF-1alpha, VEGF, and TNF-alpha l

68 ingival fibroblasts in vitro and in gingival crevicular fluid (GCF) in a randomized controlled split-

69 mpare the levels of resistin in the gingival crevicular fluid (GCF) in health, chronic periodontitis

70 to determine levels of ADAMTS-1 in gingival crevicular fluid (GCF) in patients with advanced periodo

71 IL)-11 and IL-17 and their ratio in gingival crevicular fluid (GCF) in patients with AgP.

72 trix metalloproteinase-8 (MMP-8) in gingival crevicular fluid (GCF) in patients with periodontal dise

73 al parameters of disease and on the gingival crevicular fluid (GCF) inflammatory mediator interleukin

74 of eight oral pathogens, levels of gingival crevicular fluid (GCF) interleukin-1beta (IL-1beta), pro

75 clinical periodontal parameters and gingival crevicular fluid (GCF) levels of 15-epi-lipoxin A4 (15-e

76 IgG) titers to 17 bacteria, and the gingival crevicular fluid (GCF) levels of 16 inflammatory mediato

77 The current study determines gingival crevicular fluid (GCF) levels of fibrosis-related IL-6-t

78 Comparing the gingival crevicular fluid (GCF) levels of galectin-3, peptidylarg

79 Comparing the gingival crevicular fluid (GCF) levels of galectin-3, peptidylarg

80 e of this study was to test whether gingival crevicular fluid (GCF) levels of IL-1beta and tumor necr

81 ochemical profile by evaluating the gingival crevicular fluid (GCF) levels of interleukin (IL)-17, IL

82 Gingival crevicular fluid (GCF) levels of interleukin (IL)-1beta

83 clinical periodontal parameters and gingival crevicular fluid (GCF) levels of interleukin (IL)-1beta,

84 Serum, saliva, and gingival crevicular fluid (GCF) levels of interleukin (IL)-6, IL-

85 her glycemic control was related to gingival crevicular fluid (GCF) levels of interleukin-1beta (IL-1

86 to determine the serum, saliva and gingival crevicular fluid (GCF) levels of MT in smokers (S) and n

87 gical periodontal therapy (NSPT) on gingival crevicular fluid (GCF) levels of semaphorin-4D (SEMA-4D)

88 tcome of a chairside test measuring gingival crevicular fluid (GCF) levels of the enzyme aspartate am

89 Gingival crevicular fluid (GCF) levels of the polymorphonuclear l

90 Four different gingival crevicular fluid (GCF) markers from 14 patients were cha

91 Different gingival crevicular fluid (GCF) matrix metalloproteinase (MMP)-8

92 this study is to explore different gingival crevicular fluid (GCF) matrix metalloproteinase-8 (MMP-8

93 al and microbiologic parameters and gingival crevicular fluid (GCF) matrix metalloproteinases-8 (MMP-

94 levels of immunoglobulin A (IgA) in gingival crevicular fluid (GCF) may be "protective", while increa

95 The analysis of biomarkers in gingival crevicular fluid (GCF) may be helpful in forecasting pat

96 e of inflammatory products found in gingival crevicular fluid (GCF) may be of value in evaluating bot

97 Biochemical markers harvested from gingival crevicular fluid (GCF) may be useful to identify and pre

98 Estimation of serum and gingival crevicular fluid (GCF) MCP levels could be a reliable in

99 tudy is to investigate salivary and gingival crevicular fluid (GCF) nitric oxide (NO) metabolism and

100 seline and 2 weeks postoperatively, gingival crevicular fluid (GCF) obtained at baseline, 2 weeks and

101 with their corresponding levels in gingival crevicular fluid (GCF) obtained from the same participan

102 nzyme-linked immunosorbent assay in gingival crevicular fluid (GCF) of 24 individuals with periodonti

103 agenase activity in the gingival tissues and crevicular fluid (GCF) of adult periodontitis subjects i

104 se-8, -9, and AIF were evaluated in gingival crevicular fluid (GCF) of all participants via enzyme-li

105 d products (AGEs) are higher in the gingival crevicular fluid (GCF) of chronic periodontitis (CP) pat

106 to determine visfatin levels in the gingival crevicular fluid (GCF) of healthy individuals and patien

107 is factor-alpha (TNF-alpha), in the gingival crevicular fluid (GCF) of individuals with periodontitis

108 nvestigate the levels of sTREM-1 in gingival crevicular fluid (GCF) of individuals without periodonti

109 , 2 microbiostatic proteins, in the gingival crevicular fluid (GCF) of normal children.

110 eviously demonstrated that IgG from gingival crevicular fluid (GCF) of patients with chronic periodon

111 dy was to evaluate MFN1 and MFN2 in gingival crevicular fluid (GCF) of patients with periodontal dise

112 hat ADAM8 levels are also raised in gingival crevicular fluid (GCF) of patients with periodontal dise

113 factor-kappaB ligand (RANKL) in the gingival crevicular fluid (GCF) of patients with periodontitis af

114 1 through 3 (HNP 1-3) levels in the gingival crevicular fluid (GCF) of patients with periodontitis.

115 th factor beta 1 (TGF-beta1) in the gingival crevicular fluid (GCF) of patients with periodontitis.

116 that TACE would be elevated in the gingival crevicular fluid (GCF) of persons with periodontitis.

117 radation and bone resorption in the gingival crevicular fluid (GCF) of the same vulnerable subjects.

118 This study aims to assess gingival crevicular fluid (GCF) PLAP-1, sclerostin, and TNF-alpha

119 c tromethamine mouthrinse (0.1%) on gingival crevicular fluid (GCF) prostaglandin E2 (PGE2) concentra

120 f alveolar bone, and measurement of gingival crevicular fluid (GCF) prostaglandin E2 (PGE2) levels we

121 and the differential expression of gingival crevicular fluid (GCF) proteins using sequential window

122 eome and differential expression of gingival crevicular fluid (GCF) proteins using the sequential win

123 ne naphthylamine [BANA] assay), and gingival crevicular fluid (GCF) pyridinoline cross-linked carboxy

124 Gingival crevicular fluid (GCF) samples and clinical parameters,

125 0 levels were assessed in serum and gingival crevicular fluid (GCF) samples at baseline and at variou

126 ollowing: 1) biochemical content in gingival crevicular fluid (GCF) samples from sites of gingival re

127 urements (PD, CAL, PI, BOP, GI) and gingival crevicular fluid (GCF) samples were collected at baselin

128 Clinical periodontal parameters and gingival crevicular fluid (GCF) samples were collected at baselin

129 Serum, saliva, and gingival crevicular fluid (GCF) samples were collected to measure

130 ssment of periodontal measurements, gingival crevicular fluid (GCF) samples were taken at one incisor

131 multiple inflammatory mediators in gingival crevicular fluid (GCF) samples.

132 in reaction was performed using the gingival crevicular fluid (GCF) samples.

133 livered antibiotics on the level of gingival crevicular fluid (GCF) stromelysin (SL) and tissue inhib

134 he hypothesis to be tested was that gingival crevicular fluid (GCF) TGF-beta1 production was altered

135 in are higher and more sustained in gingival crevicular fluid (GCF) than in serum.

136 clines reach steady-state levels in gingival crevicular fluid (GCF) that are several-fold higher than

137 Biofilm and gingival crevicular fluid (GCF) to assess the microbiome profile

138 Secondary purposes were to compare gingival crevicular fluid (GCF) volume and GCF concentrations of

139 ndex (PI), gingival index (GI), and gingival crevicular fluid (GCF) volume from days 0 to 21 were sig

140 GI), bleeding on probing (BOP), PD, gingival crevicular fluid (GCF) volume, and total amount and conc

141 Gingival crevicular fluid (GCF) was also collected to measure mat

142 Gingival crevicular fluid (GCF) was analyzed for the same cytokin

143 n biological profiles in saliva and gingival crevicular fluid (GCF) was assessed and compared with th

144 nical evaluation was performed, and gingival crevicular fluid (GCF) was collected for selected sites

145 on probing (BOP) were measured, and gingival crevicular fluid (GCF) was collected from five deepest p

146 Gingival crevicular fluid (GCF) was collected in a cohort of 44 A

147 e mean concentration of 0.5% CLM in gingival crevicular fluid (GCF) was estimated by reverse-phase hi

148 Gingival crevicular fluid (GCF) was obtained from 2 human studies

149 The volume of gingival crevicular fluid (GCF) was quantified, and interleukin-1

150 Gingival crevicular fluid (GCF) was sampled for the analysis of m

151 mplant crevicular fluid (PICF), and gingival crevicular fluid (GCF) were collected from patients with

152 proinflammatory cytokines level in gingival crevicular fluid (GCF) were evaluated.

153 Levels of visfatin in serum and gingival crevicular fluid (GCF) were explored in patients with pe

154 B (TGF-B) and collagen-1 (Col-1) in gingival crevicular fluid (GCF) were measured using enzyme-linked

155 Samples of gingival crevicular fluid (GCF) were obtained 1, 3, 7, 14, and 21

156 status and the enzymatic profile of gingival crevicular fluid (GCF) when given as adjunct to periodon

157 Beta-glucuronidase (betaG) in gingival crevicular fluid (GCF), a marker of neutrophil influx in

158 Saliva, gingival crevicular fluid (GCF), and blood samples from 30 patien

159 rotic cells, has been identified in gingival crevicular fluid (GCF), and elevated levels are associat

160 sion patterns of ghrelin in saliva, gingival crevicular fluid (GCF), and gingival tissue, as well as

161 gingival temperature, flow rates of gingival crevicular fluid (GCF), and neutrophil emigration into G

162 he aim of this study is to evaluate gingival crevicular fluid (GCF), saliva, and plasma levels of IL-

163 This study investigates whether gingival crevicular fluid (GCF), saliva, and plasma levels of int

164 nd TIMP-1 levels were determined in gingival crevicular fluid (GCF), saliva, and serum by immunofluor

165 im of this study is to evaluate the gingival crevicular fluid (GCF), saliva, and serum concentrations

166 Gingival crevicular fluid (GCF), saliva, and serum levels of IL-6

167 macokinetic data were obtained from gingival crevicular fluid (GCF), saliva, and serum of adult perio

168 17A/F, and IL-17E (IL-25) levels in gingival crevicular fluid (GCF), saliva, and serum of non-obese f

169 Gingival crevicular fluid (GCF), serum, and saliva samples were o

170 as well as gingival tissue (GT) and gingival crevicular fluid (GCF), was obtained from a total of 35

171 th factor beta 1 (TGF-beta1) in the gingival crevicular fluid (GCF), which accumulates around the nec

172 ta on microbial plaque composition, gingival crevicular fluid (GCF)-interleukin (IL)-1beta levels, an

173 sis factor-alpha (TNF-alpha) in the gingival crevicular fluid (GCF).

174 strates are different in saliva vs. gingival crevicular fluid (GCF).

175 nti-PC and anti-oxLDL production in gingival crevicular fluid (GCF).

176 ponses and tissue remodeling in the gingival crevicular fluid (GCF).

177 ino acid, enters the oral cavity in gingival crevicular fluid (GCF).

178 dy are to comparatively analyze the gingival crevicular fluid (GCF)/peri-implant sulcus fluid (PISF)

179 9 days) were compared with adjacent gingival crevicular fluid (GCF; at baseline, 1, and 4 months).

180 1alpha, GPX4, and MDA levels in peri-implant crevicular fluid (PICF) across peri-implant health, muco

181 ytokine levels were measured in peri-implant crevicular fluid (PICF) and gingival crevicular fluid (G

182 ecific inflammatory cytokine in peri-implant crevicular fluid (PICF) compared with healthy patients;

183 The proteome of the peri-implant crevicular fluid (PICF) has not been systematically inve

184 NA-150-5p, and miRNA-26a-5p) in peri-implant crevicular fluid (PICF) of subjects with healthy, peri-i

185 Peri-implant crevicular fluid (PICF) samples from the new implant and

186 Clinical measurements and peri-implant crevicular fluid (PICF) were taken at 1-, 2-, 4-, and 6-

187 Serum, peri-implant crevicular fluid (PICF), and gingival crevicular fluid (

188 udy assesses cytokine levels in peri-implant crevicular fluid (PICF)/gingival crevicular fluid (GCF)

189 uld enhance DOX availability in the gingival crevicular fluid after its release from the collagen mem

190 ilm as well as on biomarkers in the gingival crevicular fluid after SRP.

191 of host markers in serum/plasma and gingival crevicular fluid along with clinical parameter improveme

192 rails to reduce MMP activity in the gingival crevicular fluid and gingival tissues, with a resultant

193 iodontitis have type-1 cytokines in gingival crevicular fluid and high titers of IFN-gamma-dependent

194 IgG2 reactive with P. gingivalis in gingival crevicular fluid and serum.

195 and is detected at higher levels in gingival crevicular fluid and tissue specimens.

196 Measures of gingival inflammation, crevicular fluid aspartate aminotransferase (AST) levels

197 Bioassay of doxycycline in gingival crevicular fluid associated with presence of ABDS-D gave

198 ted whole-mouth salivary flow rate, gingival crevicular fluid biomarkers).

199 leeding on probing (BOP) as well as gingival crevicular fluid bone marker assessment (ICTP) and micro

200 e if levels of IL-1alpha protein in gingival crevicular fluid can be correlated to patient genotype.

201 performed a metabolomic analysis of gingival crevicular fluid collected from healthy, gingivitis, and

202 The analysis of gingival crevicular fluid components offers great potential as a

203 dontal pockets, which are bathed in gingival crevicular fluid consisting of 70% of blood plasma, an a

204 s of gingipain activity detected in gingival crevicular fluid could implicate a role for gingipains i

205 be used for measuring ions from the gingival crevicular fluid directly into the peri-odontal pocket,

206 ics at concentrations detectable in gingival crevicular fluid do not dramatically reduce total bacter

207 The reduction in crevicular fluid flow at control sites suggested that cl

208 ol sites, a significant decrease in gingival crevicular fluid flow rate was evident at the conclusion

209 galactose-deficient IgG in sera and gingival crevicular fluid from periodontal disease patients, comp

210 segments of FN and used to analyze gingival crevicular fluid from periodontal disease sites in syste

211 nd between DHA and control for both gingival crevicular fluid hsCRP (-5.3 ng/mL, standard error [SE]

212 s) and local inflammatory response (gingival crevicular fluid IL-1beta) and derive periodontal comple

213 rom real samples, such as saliva or gingival crevicular fluid in a short time as a point-of-care (POC

214 e the levels of these biomarkers in gingival crevicular fluid in periodontal health, gingivitis, and

215 nical parameters were recorded, and gingival crevicular fluid levels of biomarkers were analyzed by e

216 pth, clinical attachment level, and gingival crevicular fluid levels of matrix metalloproteinases (MM

217 e loss, which correlated with lower gingival crevicular fluid levels of proinflammatory mediators (e.

218 ponse to a major human salivary and gingival crevicular fluid LPA species, 18:1, and that they would

219 l parameters and cytokine levels in gingival crevicular fluid of dogs with experimental periodontitis

220 parameters and cytokine profiles in gingival crevicular fluid of patients with moderate-to-severe chr

221 nes were evaluated in the serum and gingival crevicular fluid of shallow and deep sites by enzyme-lin

222 depths, gingival inflammation, and gingival crevicular fluid RANKL and MMP-8 levels (p < 0.05).

223 uated clinically and biochemically (gingival crevicular fluid RANKL, OPG, MMP-8, and serum IL-1beta l

224 (MD) on clinical parameters and peri-implant crevicular fluid receptor activator of nuclear factor-ka

225 Total RNA was extracted from gingival crevicular fluid samples and relative gene expression of

226 Peri-implant crevicular fluid samples collected from 164 participants

227 ected the karilysin gene in >90% of gingival crevicular fluid samples containing T. forsythia obtaine

228 Detection of these gene products in gingival crevicular fluid samples from human disease may contribu

229 in the pathogenesis of periodontal disease, crevicular fluid samples from LAgP patients were found t

230 Gingival crevicular fluid samples from six healthy, six gingiviti

231 iagnostic efficacy was evaluated in gingival crevicular fluid samples from subjects with and without

232 Gingival crevicular fluid samples were analyzed for changes in hi

233 Marginal and subgingival plaque and gingival crevicular fluid samples were collected at baseline; aft

234 Clinical parameters and peri-implant crevicular fluid samples were collected baseline and 6 m

235 Marginal and subgingival plaque and gingival crevicular fluid samples were collected from 15 current

236 Subgingival plaque and crevicular fluid samples were collected from 31 systemic

237 Gingival tissues and crevicular fluid samples were collected.

238 Gingival crevicular fluid samples were used to monitor daily drug

239 examination; blood, subgingival plaque, and crevicular fluid specimen collection; and medical and de

240 ignificantly higher IL-1beta in the gingival crevicular fluid than females during health and periodon

241 oncentrations were estimated in peri-implant crevicular fluid using enzyme-linked immunosorbent assay

242 dex (PlI), gingival index (GI), and gingival crevicular fluid volume (GCF) were evaluated for teeth 6

243 ive attachment levels (RAL); and 5) gingival crevicular fluid volume (GCF).

244 In addition, gingival crevicular fluid was analyzed for an inflammation index

245 Gingival crevicular fluid was collected before treatment, after 1

246 The mean concentration of MF in gingival crevicular fluid was estimated by reverse-phase high-per

247 Samples of subgingival biofilm and gingival crevicular fluid were collected at baseline and at 1-, 3

248 Plaque and gingival crevicular fluid were collected for trypsin-like enzyme

249 ed hemoglobin, and immunological analysis of crevicular fluid were evaluated.

250 specific immunoglobulin G levels in gingival crevicular fluid were measured in primates immunized wit

251 Samples of gingival crevicular fluid were obtained 1, 3, 7, 14, and 21 days

252 Recipient (gingival crevicular fluid) and donor (wound fluid) site VEGF-A, H

253 and measured MMP-9 levels in their gingival crevicular fluid, a liquid that seeps out from the tiny

254 l and inflammatory cytokines in the gingival crevicular fluid, and a synergistic effect was observed,

255 are secreted--specifically saliva, gingival crevicular fluid, and airway surface fluid--differ great

256 effect on alveolar bone, effect on gingival crevicular fluid, and effect on salivary flow.

257 e examined whether IgG in serum and gingival crevicular fluid, and IgG locally produced by plasma cel

258 Saliva, salivary glands, gingival crevicular fluid, and supragingival biofilms may harbor

259 Gingival crevicular fluid, bleeding on probing (BOP), and interle

260 inase (MMP) activity in gingival tissues and crevicular fluid, in association with clinical efficacy,

261 Saliva, gingival crevicular fluid, subgingival plaque, and blood samples

262 on probing [BOP]) and a sampling of gingival crevicular fluid, the composite restoration was performe

263 up to 70% of serum concentration in gingival crevicular fluid.

264 8 selected inflammatory markers measured in crevicular fluid.

265 Crevicular fluids from localized juvenile periodontitis

266 t level, and bleeding on probing, as well as crevicular levels of interleukin-1beta and tumor necrosi

267 of AP induces a downregulation of amplified crevicular neutrophil activity.

268 lysis of betaG in saliva may be a measure of crevicular neutrophil influx for the whole mouth.

269 rinse enhances the antibacterial function of crevicular neutrophils.

270 orrelation between gingival inflammation and crevicular pH, which reportedly varies from 6.5 to 8.5.

271 Tissue sulfiredoxin and crevicular TOS levels are increased significantly in the

272 rrelate the gingival tissue sulfiredoxin and crevicular total oxidative stress (TOS) levels in genera